L eopoldo Espinosa Abdalá is a Mexican businessman who, along with his brother Fernando, inherited and expanded Laboratorios Rimsa, a pharmaceutical company founded by their father in 1970. Based in Guadalajara, Rimsa became a significant player in the Mexican market, known for its innovative fixed-dose combination drugs and patented delivery systems. Leopoldo served as the executive president, steering the family business towards high profitability and market leadership.

In 2016, the brothers sold Rimsa to the Israeli pharmaceutical giant Teva Pharmaceuticals for a staggering $2.3 billion. The deal was one of the largest in the sector's history in Mexico but was followed by a contentious legal battle where Teva accused the brothers of fraud regarding the company's manufacturing processes. The dispute was eventually settled, and Leopoldo retained the bulk of his fortune from the sale. He now focuses on managing his wealth through diverse investments.

Quick Reads:

• Former Executive President of Laboratorios Rimsa.
• Sold the family pharmaceutical company to Teva for $2.3 billion in 2016.
• Inherited the business from his father, who founded it in 1970.
• Known for developing fixed-dose combination drugs.
• Engaged in a high-profile legal battle with Teva post-sale.